Nifedipine gastrointestinal therapeutic system: An overview of its antiatherosclerotic effects

Expert Opinion on Drug Metabolism and Toxicology

Volumn 3, Issue 5, 2007, Pages 769-780

  Ueng, Kwo Chang ^a   Lin, Ming Cheng ^a   Chan, Kuei Chuan ^a   Lin, Chung Sheng ^a  

^a CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Atherosclerosis; Calcium antagonist; Hypertension; Nifedipine

Indexed keywords

ACETYLSALICYLIC ACID; AMILORIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BILE ACID SEQUESTRANT; CALCIUM; CERIVASTATIN; CYTOCHROME P450 3A4; ENALAPRIL; FIBRIC ACID DERIVATIVE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROCHLOROTHIAZIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVINOLIN; NIFEDIPINE; PLACEBO; TRIACYLGLYCEROL; CALCIUM CHANNEL BLOCKING AGENT;

ARTERY INTIMA PROLIFERATION; ATHEROSCLEROTIC PLAQUE; CALCIUM CELL LEVEL; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED DRUG RELEASE; CORONARY ARTERY ATHEROSCLEROSIS; CORRELATION ANALYSIS; DIZZINESS; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG METABOLISM; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ENDOTHELIAL DYSFUNCTION; FLUSHING; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL TRACT; HEART PALPITATION; HIGH RISK PATIENT; HUMAN; HYPERTENSION; HYPOTENSION; LIFESTYLE MODIFICATION; METABOLIC SYNDROME X; NONHUMAN; PERIPHERAL EDEMA; REVIEW; SIDE EFFECT; SLOW DRUG RELEASE; STABLE ANGINA PECTORIS; TABLET FORMULATION; TACHYCARDIA; VASCULAR RESISTANCE; VASODILATATION; ANIMAL; ATHEROSCLEROSIS; DELAYED RELEASE FORMULATION;

ANGINA; ANIMALIA;

ANIMALS; ATHEROSCLEROSIS; CALCIUM CHANNEL BLOCKERS; CLINICAL TRIALS AS TOPIC; DELAYED-ACTION PREPARATIONS; HUMANS; NIFEDIPINE;

EID: 85047681106     PISSN: 17425255     EISSN: None     Source Type: Journal    
DOI: 10.1517/17425255.3.5.769     Document Type: Review

References (101)